ProMIS Neurosciences Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
PMN on Nasdaq
Industry
Pharmaceutical Preparations
Location
Suite 200, 1920 Yonge Street, Toronto, Ontario, Canada

Insiders trading volume in the past year

ProMIS Neurosciences Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jeremy M. Sclar 10%+ Owner $10.6M Jul 25, 2025
Shaf QIC LLC 10%+ Owner $3.27M Jul 29, 2025
ABG Management Ltd. 10%+ Owner $3.03M Oct 22, 2025
Slanix Paul Alex Director $2.57M Oct 22, 2025
Jeremy M. Sclar 2012 Irrevocable Family Trust 10%+ Owner $2.34M Jul 25, 2025
Michael S. Gordon Other* $1.53M Jul 25, 2025
Title 19 Promis Other* $1.22M Jul 25, 2025
Madge K. Shafmaster Director $271K Jun 12, 2025
Gail M. Farfel Chief Executive Officer, Director $256K Aug 23, 2023
Neil Cashman Chief Scientific Officer, Director $126K +$14.6K +13.1% Sep 22, 2025
Patrick Kirwin Director $124K Jun 12, 2025
Max A. Milbury Principal Accounting Officer $22.3K +$14.9K +203% Oct 3, 2025
Gavin T. Malenfant Chief Operating Officer, Director $12.3K Oct 26, 2023
Larry Altstiel Chief Medical Officer Sep 22, 2025
Johanne Kaplan Chief Development Officer Sep 22, 2025
Neil Warma Chief Executive Officer, Director Sep 22, 2025
Josh Mandel-Brehm Director Jun 12, 2025
Richard J. Gregory Director Jul 7, 2022
Eugene Williams Director Jun 12, 2025
Daniel E. Geffken Chief Financial Officer Oct 26, 2023
William Wyman Director Jun 12, 2025

Recent Insider Transactions by Companies or Individuals for ProMIS Neurosciences Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.